Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisatio
As part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains the many ways digital can enhance the customer journey – so long as t
Astellas has added another gene therapy to its pipeline, taking an option on a clinical-stage candidate for a rare genetic form of dementia from UK biotech AviadoBio for around $50 million.